S.T. Dupont S.A.

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 92.9M. In comparison, MC.PA has a market cap of 226.5B. Regarding current trading prices, DPT.PA is priced at €0.10, while MC.PA trades at €456.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -9.84, whereas MC.PA's P/E ratio is 20.70. In terms of profitability, DPT.PA's ROE is -0.04%, compared to MC.PA's ROE of +0.19%. Regarding short-term risk, DPT.PA is less volatile compared to MC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DPT.PA.Check MC.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 92.9M. In comparison, RMS.PA has a market cap of 219.6B. Regarding current trading prices, DPT.PA is priced at €0.10, while RMS.PA trades at €2,095.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -9.84, whereas RMS.PA's P/E ratio is 49.18. In terms of profitability, DPT.PA's ROE is -0.04%, compared to RMS.PA's ROE of +0.28%. Regarding short-term risk, DPT.PA is more volatile compared to RMS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DPT.PA.Check RMS.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 92.9M. In comparison, CDI.PA has a market cap of 79.5B. Regarding current trading prices, DPT.PA is priced at €0.10, while CDI.PA trades at €440.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -9.84, whereas CDI.PA's P/E ratio is 17.46. In terms of profitability, DPT.PA's ROE is -0.04%, compared to CDI.PA's ROE of +0.22%. Regarding short-term risk, DPT.PA is less volatile compared to CDI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DPT.PA.Check CDI.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 92.9M. In comparison, KER.PA has a market cap of 25.9B. Regarding current trading prices, DPT.PA is priced at €0.10, while KER.PA trades at €211.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -9.84, whereas KER.PA's P/E ratio is 35.77. In terms of profitability, DPT.PA's ROE is -0.04%, compared to KER.PA's ROE of +0.08%. Regarding short-term risk, DPT.PA is less volatile compared to KER.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DPT.PA.Check KER.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 92.9M. In comparison, MLCLI.PA has a market cap of 7.9M. Regarding current trading prices, DPT.PA is priced at €0.10, while MLCLI.PA trades at €2.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -9.84, whereas MLCLI.PA's P/E ratio is N/A. In terms of profitability, DPT.PA's ROE is -0.04%, compared to MLCLI.PA's ROE of +0.00%. Regarding short-term risk, DPT.PA is less volatile compared to MLCLI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DPT.PA.Check MLCLI.PA's competition here